Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 29 studies | 39% ± 13% | |
endothelial cell | 26 studies | 34% ± 13% | |
pericyte | 25 studies | 48% ± 16% | |
smooth muscle cell | 23 studies | 45% ± 20% | |
connective tissue cell | 13 studies | 40% ± 15% | |
myofibroblast cell | 11 studies | 36% ± 11% | |
endothelial cell of artery | 11 studies | 41% ± 19% | |
capillary endothelial cell | 10 studies | 31% ± 13% | |
vein endothelial cell | 9 studies | 26% ± 8% | |
mesothelial cell | 6 studies | 34% ± 17% | |
endothelial cell of vascular tree | 6 studies | 35% ± 12% | |
basal cell | 4 studies | 28% ± 11% | |
epithelial cell | 3 studies | 39% ± 17% | |
adventitial cell | 3 studies | 40% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 31% ± 1% | |
ciliated cell | 3 studies | 26% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 2049.54 | 177 / 180 | 98% | 28.76 | 422 / 430 |
esophagus | 82% | 2828.40 | 1182 / 1445 | 99% | 26.06 | 181 / 183 |
skin | 87% | 2292.09 | 1576 / 1809 | 92% | 27.73 | 435 / 472 |
uterus | 100% | 4979.13 | 170 / 170 | 76% | 13.27 | 348 / 459 |
intestine | 86% | 2637.97 | 831 / 966 | 82% | 17.56 | 433 / 527 |
breast | 98% | 2873.66 | 451 / 459 | 68% | 8.03 | 763 / 1118 |
bladder | 95% | 4234.90 | 20 / 21 | 71% | 11.70 | 359 / 504 |
lung | 91% | 2127.86 | 525 / 578 | 75% | 12.05 | 862 / 1155 |
stomach | 76% | 1641.34 | 274 / 359 | 89% | 23.43 | 254 / 286 |
kidney | 75% | 1162.29 | 67 / 89 | 87% | 23.76 | 782 / 901 |
adrenal gland | 78% | 953.59 | 201 / 258 | 80% | 12.78 | 184 / 230 |
prostate | 96% | 2515.69 | 234 / 245 | 62% | 5.69 | 311 / 502 |
pancreas | 45% | 471.58 | 149 / 328 | 91% | 22.75 | 162 / 178 |
thymus | 80% | 1230.50 | 521 / 653 | 54% | 4.33 | 326 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.80 | 1 / 1 |
blood vessel | 100% | 10903.26 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 3506.24 | 1192 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 1984.44 | 822 / 861 | 0% | 0 | 0 / 0 |
spleen | 85% | 1283.92 | 204 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 8.59 | 34 / 45 |
eye | 0% | 0 | 0 / 0 | 75% | 14.41 | 60 / 80 |
lymph node | 0% | 0 | 0 / 0 | 72% | 7.28 | 21 / 29 |
liver | 3% | 29.54 | 7 / 226 | 32% | 3.84 | 130 / 406 |
muscle | 25% | 289.96 | 200 / 803 | 0% | 0 | 0 / 0 |
brain | 2% | 23.38 | 62 / 2642 | 16% | 1.62 | 110 / 705 |
peripheral blood | 2% | 15.32 | 14 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901003 | Biological process | negative regulation of fermentation |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0030866 | Biological process | cortical actin cytoskeleton organization |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0005901 | Cellular component | caveola |
GO_0005737 | Cellular component | cytoplasm |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CAVIN3 |
Protein name | Caveolae-associated protein 3 (Cavin-3) (Protein kinase C delta-binding protein) (Serum deprivation response factor-related gene product that binds to C-kinase) (hSRBC) Caveolae associated protein 3 |
Synonyms | SRBC PRKCDBP |
Description | FUNCTION: Regulates the traffic and/or budding of caveolae . Plays a role in caveola formation in a tissue-specific manner. Required for the formation of caveolae in smooth muscle but not in the lung and heart endothelial cells. Regulates the equilibrium between cell surface-associated and cell surface-dissociated caveolae by promoting the rapid release of caveolae from the cell surface. Plays a role in the regulation of the circadian clock. Modulates the period length and phase of circadian gene expression and also regulates expression and interaction of the core clock components PER1/2 and CRY1/2 (By similarity). . |
Accessions | ENST00000303927.4 ENST00000530979.1 E9PIE3 Q969G5 |